Remember last year around back-to-school time, when the public focused its ire on drug company Mylan for charging hundreds of dollars for $1 worth of the drug epinephrine in each EpiPen brand auto-injector? While that generated plenty of bad publicity for Mylan, turns out Mylan doesn’t actually care. [More]
